Literature DB >> 18941468

Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats.

Rohit Sood1, Yi Yang, Saeid Taheri, Eduardo Candelario-Jalil, Eduardo Y Estrada, Espen J Walker, Jeffrey Thompson, Gary A Rosenberg.   

Abstract

White matter (WM) injury after bilateral common carotid artery occlusion (BCAO) in rat is associated with disruption of the blood-brain barrier (BBB) by matrix metalloproteinases (MMPs). We hypothesized that WM injury as seen on magnetic resonance imaging (MRI) would correlate with regions of increased MMP activity. MRI was performed 3 days after BCAO surgery in rats. Apparent diffusion coefficients (ADC) were calculated and vascular permeability was quantified by the multiple-time graphical analysis (MTGA) method, using gadolinium-diethylenetriamine pentaacid (Gd-DTPA). After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, MMP-9, tight junction proteins (TJPs), and in situ zymography. We found that ADC values were increased in WM in BCAO rats compared with controls (P<0.05). WM with increased ADC had leakage of EB. MMP-2 and MMP-9 activity on in situ zymograms corresponded with leakage of EB. Although increased permeability to EB could be visualized, permeability quantification with (14)C-sucrose and Gd-DTPA failed to show increases and TJPs were intact. We propose that increased ADC, which is a marker of vasogenic edema, is related to activity of MMP-2 and MMP-9. MRI provides unique information that can be used to guide tissue studies of WM injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941468     DOI: 10.1038/jcbfm.2008.121

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  29 in total

1.  Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology.

Authors:  Angelika Hoffmann; Jörg Bredno; Michael F Wendland; Nikita Derugin; Jason Hom; Tibor Schuster; Hua Su; Peter T Ohara; William L Young; Max Wintermark
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

Review 2.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

3.  Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats.

Authors:  Francesco Blasi; Michael J Whalen; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-04       Impact factor: 6.200

4.  Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.

Authors:  Ankur Jindal; Sathyanarayanan Rajagopal; Lucas Winter; Joshua W Miller; Donald W Jacobsen; Jonathan Brigman; Andrea M Allan; Surojit Paul; Ranjana Poddar
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

5.  Myelin loss associated with neuroinflammation in hypertensive rats.

Authors:  Fakhreya Y Jalal; Yi Yang; Jeffrey Thompson; Anita C Lopez; Gary A Rosenberg
Journal:  Stroke       Date:  2012-02-23       Impact factor: 7.914

Review 6.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey Thompson; Gary A Rosenberg
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

Review 7.  Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.

Authors:  Akihiro Shindo; Anna C Liang; Takakuni Maki; Nobukazu Miyamoto; Hidekazu Tomimoto; Eng H Lo; Ken Arai
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

8.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

9.  Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

Authors:  Devika S Manickam; Anna M Brynskikh; Jennifer L Kopanic; Paul L Sorgen; Natalia L Klyachko; Elena V Batrakova; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2012-08-10       Impact factor: 9.776

Review 10.  Matrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger Type.

Authors:  Gary A Rosenberg
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.